Phase I clinical and pharmacologic study of docetaxel and gemcitabine in patients with advanced solid tumors; a novel two week schedule

被引：0
|
作者：
Obrocea, M
Davis, TH
Lewis, LD
Maurer, LH
Pipas, JM
Smith, EL
Meyer, LP
Hammond, S
Rigas, JR
机构：
[1] Dartmouth Coll, Hitchcock Med Ctr, Lebanon, NH 03756 USA
[2] Norris Cotton Canc Ctr, Lebanon, NH 03756 USA
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
363
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [41] Phase I study of docetaxel and topotecan in patients with solid tumors
    Tkaczuk, KH
    Zamboni, WC
    Tait, NS
    Meisenberg, BR
    Doyle, LA
    Edelman, MJ
    Hausner, PF
    Egorin, MJ
    Van Echo, DA
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (06) : 442 - 448
  • [42] Phase I dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors
    Masters, GA
    Brockstein, BE
    Mani, S
    Ratain, MJ
    MEDICAL ONCOLOGY, 2003, 20 (01) : 7 - 12
  • [43] Phase I dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors
    Gregory A. Masters
    Bruce E. Brockstein
    Sridhar Mani
    Mark J. Ratain
    Medical Oncology, 2003, 20 : 7 - 12
  • [44] Phase I and pharmacologic study of a weekly schedule of LEP (liposome encapsulated paclitaxel) in patients with solid tumors.
    Soepenberg, O
    Sparreboom, A
    de Jonge, MJ
    Paolini, J
    Angiuli, P
    Breda, M
    Bowden, C
    Verweij, J
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3673S - 3673S
  • [45] Phase I study of the gemcitabine/oxaliplatin combination in patients with advanced solid tumors: A preliminary report
    Mavroudis, D
    Kourousis, C
    Kakolyris, S
    Agelaki, S
    Kalbakis, K
    Androulakis, N
    Souglakos, J
    Vardakis, N
    Samonis, G
    Georgoulias, V
    SEMINARS IN ONCOLOGY, 2000, 27 (01) : 25 - 30
  • [46] A phase I clinical and pharmacokinetic study of oral CI-1033 in combination with docetaxel in patients with advanced solid tumors
    Garland, Linda L.
    Hidalgo, Manuel
    Mendelson, David S.
    Ryan, David P.
    Arun, Banu K.
    Lovalvo, Jennifer L.
    Eiseman, Irene A.
    Olson, Stephen C.
    Lenehan, Peter F.
    Eder, Joseph P.
    CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4274 - 4282
  • [47] A phase I study of flavopiridol using an alternative schedule in patients (pts) with advanced solid tumors
    Ramaswamy, B.
    Phelps, M.
    Baiocchi, R.
    Bekaii-Saab, T.
    Wilkins, D.
    Arbogast, D.
    Campbell, A.
    Doyle, A. L.
    Grever, M.
    Shah, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] Phase I study of E7389/gemcitabine combination in patients with advanced solid tumors
    Goel, R.
    Chen, E.
    Welch, S.
    Laurie, S.
    Siu, L.
    Jonker, D.
    Srinivasan, R.
    Wang, L.
    Ivy, P.
    Oza, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [49] NCCAM/NCI phase I study of mistletoe extract and gemcitabine in patients with advanced solid tumors
    Mansky, P. J.
    Wallerstedt, D. B.
    Sannes, T.
    Stagl, J.
    Johnson, L.
    Blackman, M. R.
    Grem, J. L.
    Swain, S. M.
    Monahan, B. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer
    Bhargava, P
    Marshall, JL
    Fried, K
    Williams, M
    Lefebvre, P
    Dahut, W
    Hanfelt, J
    Gehan, E
    Figuera, M
    Hawkins, MJ
    Rizvi, NA
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (02) : 95 - 103
12345